BPC
ALXN

Banque Pictet & Cie’s Alexion Pharmaceuticals ALXN Stock Holding History

Banque Pictet & Cie’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,090
Closed -$2.59M – 364
2021
Q2 		$2.59M Sell
14,090
-5,509
-28% -$946K 0.03% 185
2021
Q1 		$3M Sell
19,599
-600
-3% -$92.8K 0.04% 175
2020
Q4 		$3.16M Sell
20,199
-10,089
-33% -$1.3M 0.04% 167
2020
Q3 		$3.47M Buy
30,288
+12,307
+68% +$1.33M 0.05% 159
2020
Q2 		$2.02M Sell
17,981
-2,067
-10% -$219K 0.03% 189
2020
Q1 		$1.8M Buy
20,048
+608
+3% +$59.7K 0.04% 186
2019
Q4 		$2.1M Buy
19,440
+7,540
+63% +$806K 0.04% 199
2019
Q3 		$1.17M Sell
11,900
-330
-3% -$37.2K 0.02% 214
2019
Q2 		$1.6M Sell
12,230
-19,430
-61% -$2.5M 0.03% 193
2019
Q1 		$4.28M Sell
31,660
-18,185
-36% -$2.26M 0.08% 143
2018
Q4 		$4.85M Sell
49,845
-2,470
-5% -$292K 0.1% 132
2018
Q3 		$7.27M Sell
52,315
-6,973
-12% -$875K 0.13% 118
2018
Q2 		$7.36M Sell
59,288
-21,387
-27% -$2.5M 0.14% 110
2018
Q1 		$8.99M Sell
80,675
-545
-0.7% -$65.1K 0.19% 90
2017
Q4 		$9.71M Buy
81,220
+35,548
+78% +$4.33M 0.19% 76
2017
Q3 		$6.41M Sell
45,672
-10,948
-19% -$1.49M 0.15% 126
2017
Q2 		$6.89M Buy
56,620
+19,767
+54% +$2.3M 0.16% 107
2017
Q1 		$4.47M Buy
+36,853
New +$4.75M 0.11% 137

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Banque Pictet & Cie's ALXN Position: Q3 2021 in Review

Banque Pictet & Cie sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 14,090 shares — an estimated $2.59M sold.

Banque Pictet & Cie first reported a position in ALXN in Q1 2017 and held it in 18 quarters. The position peaked at $9.71M in Q4 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Banque Pictet & Cie reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Banque Pictet & Cie sold 14,090 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.59M.
  • Banque Pictet & Cie first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 18 quarters.
  • Banque Pictet & Cie's Alexion Pharmaceuticals position peaked at $9.71M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Banque Pictet & Cie's 13F filing for Q3 2021, filed 10 Nov 2021.